HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease

Sunanda Kane, John B Kisiel, Lorena Shih, Stephen Hanauer

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

OBJECTIVES: Inflammatory bowel disease (IBD) activity during pregnancy is variable and factors influencing the course unknown. We studied the relationship between maternal-fetal HLA disparity and IBD course. METHODS: Women with IBD and childbirth were recruited and medical records were reviewed for five time periods. Twenty milliliters of blood was obtained from mother and child for genotyping. Each mother/child pair was assigned an HLA disparity status (±) for HLA A, B, C, DRB1, and DQ loci. Odds ratios were calculated comparing HLA disparity in women whose IBD improved versus those whose disease worsened or remained active. RESULTS: Fifty pregnancies in 38 women were studied. Forty-two of 50 pregnancies (84%) were disparate at the DRB1 locus; 34 (68%) were mismatched at the DQ locus. There was no difference in average disease score or overall activity score based on DRB1 or DQ disparity (p > 0.05 for all comparisons). There were 31 pregnancies disparate at both DRB1 and DQ loci; a significant difference was found in average disease scores and overall activity scores between women mismatched at both loci versus only one or neither locus (OR 8.4 [1.5-14, p = 0.01). Logistic regression identified prepartum disease activity and disparity at both DRB1 and DQ as significant predictors of overall disease activity during pregnancy. CONCLUSION: Improvement of IBD symptoms during pregnancy is associated with disparity in HLA class II antigens between mother and fetus. This suggests that the maternal immune response to paternal HLA antigens plays a role in pregnancy-induced remission. What is accepted and what this research adds are as follows: The course of IBD during pregnancy is variable; The factors involved with disease course are unknown; The data presented here provides a scientific mechanism for disease course during pregnancy; This is a novel work and it corroborates what has been seen in other autoimmune conditions.

Original languageEnglish (US)
Pages (from-to)1523-1526
Number of pages4
JournalAmerican Journal of Gastroenterology
Volume99
Issue number8
DOIs
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Inflammatory Bowel Diseases
Pregnancy
Mothers
HLA Antigens
HLA-A Antigens
HLA-B Antigens
Histocompatibility Antigens Class II
Medical Records
Fetus
Logistic Models
Odds Ratio
Parturition
Research

ASJC Scopus subject areas

  • Gastroenterology

Cite this

HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. / Kane, Sunanda; Kisiel, John B; Shih, Lorena; Hanauer, Stephen.

In: American Journal of Gastroenterology, Vol. 99, No. 8, 08.2004, p. 1523-1526.

Research output: Contribution to journalArticle

@article{e340e4bb169d4358942723ab01a64dd8,
title = "HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease",
abstract = "OBJECTIVES: Inflammatory bowel disease (IBD) activity during pregnancy is variable and factors influencing the course unknown. We studied the relationship between maternal-fetal HLA disparity and IBD course. METHODS: Women with IBD and childbirth were recruited and medical records were reviewed for five time periods. Twenty milliliters of blood was obtained from mother and child for genotyping. Each mother/child pair was assigned an HLA disparity status (±) for HLA A, B, C, DRB1, and DQ loci. Odds ratios were calculated comparing HLA disparity in women whose IBD improved versus those whose disease worsened or remained active. RESULTS: Fifty pregnancies in 38 women were studied. Forty-two of 50 pregnancies (84{\%}) were disparate at the DRB1 locus; 34 (68{\%}) were mismatched at the DQ locus. There was no difference in average disease score or overall activity score based on DRB1 or DQ disparity (p > 0.05 for all comparisons). There were 31 pregnancies disparate at both DRB1 and DQ loci; a significant difference was found in average disease scores and overall activity scores between women mismatched at both loci versus only one or neither locus (OR 8.4 [1.5-14, p = 0.01). Logistic regression identified prepartum disease activity and disparity at both DRB1 and DQ as significant predictors of overall disease activity during pregnancy. CONCLUSION: Improvement of IBD symptoms during pregnancy is associated with disparity in HLA class II antigens between mother and fetus. This suggests that the maternal immune response to paternal HLA antigens plays a role in pregnancy-induced remission. What is accepted and what this research adds are as follows: The course of IBD during pregnancy is variable; The factors involved with disease course are unknown; The data presented here provides a scientific mechanism for disease course during pregnancy; This is a novel work and it corroborates what has been seen in other autoimmune conditions.",
author = "Sunanda Kane and Kisiel, {John B} and Lorena Shih and Stephen Hanauer",
year = "2004",
month = "8",
doi = "10.1111/j.1572-0241.2004.30472.x",
language = "English (US)",
volume = "99",
pages = "1523--1526",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease

AU - Kane, Sunanda

AU - Kisiel, John B

AU - Shih, Lorena

AU - Hanauer, Stephen

PY - 2004/8

Y1 - 2004/8

N2 - OBJECTIVES: Inflammatory bowel disease (IBD) activity during pregnancy is variable and factors influencing the course unknown. We studied the relationship between maternal-fetal HLA disparity and IBD course. METHODS: Women with IBD and childbirth were recruited and medical records were reviewed for five time periods. Twenty milliliters of blood was obtained from mother and child for genotyping. Each mother/child pair was assigned an HLA disparity status (±) for HLA A, B, C, DRB1, and DQ loci. Odds ratios were calculated comparing HLA disparity in women whose IBD improved versus those whose disease worsened or remained active. RESULTS: Fifty pregnancies in 38 women were studied. Forty-two of 50 pregnancies (84%) were disparate at the DRB1 locus; 34 (68%) were mismatched at the DQ locus. There was no difference in average disease score or overall activity score based on DRB1 or DQ disparity (p > 0.05 for all comparisons). There were 31 pregnancies disparate at both DRB1 and DQ loci; a significant difference was found in average disease scores and overall activity scores between women mismatched at both loci versus only one or neither locus (OR 8.4 [1.5-14, p = 0.01). Logistic regression identified prepartum disease activity and disparity at both DRB1 and DQ as significant predictors of overall disease activity during pregnancy. CONCLUSION: Improvement of IBD symptoms during pregnancy is associated with disparity in HLA class II antigens between mother and fetus. This suggests that the maternal immune response to paternal HLA antigens plays a role in pregnancy-induced remission. What is accepted and what this research adds are as follows: The course of IBD during pregnancy is variable; The factors involved with disease course are unknown; The data presented here provides a scientific mechanism for disease course during pregnancy; This is a novel work and it corroborates what has been seen in other autoimmune conditions.

AB - OBJECTIVES: Inflammatory bowel disease (IBD) activity during pregnancy is variable and factors influencing the course unknown. We studied the relationship between maternal-fetal HLA disparity and IBD course. METHODS: Women with IBD and childbirth were recruited and medical records were reviewed for five time periods. Twenty milliliters of blood was obtained from mother and child for genotyping. Each mother/child pair was assigned an HLA disparity status (±) for HLA A, B, C, DRB1, and DQ loci. Odds ratios were calculated comparing HLA disparity in women whose IBD improved versus those whose disease worsened or remained active. RESULTS: Fifty pregnancies in 38 women were studied. Forty-two of 50 pregnancies (84%) were disparate at the DRB1 locus; 34 (68%) were mismatched at the DQ locus. There was no difference in average disease score or overall activity score based on DRB1 or DQ disparity (p > 0.05 for all comparisons). There were 31 pregnancies disparate at both DRB1 and DQ loci; a significant difference was found in average disease scores and overall activity scores between women mismatched at both loci versus only one or neither locus (OR 8.4 [1.5-14, p = 0.01). Logistic regression identified prepartum disease activity and disparity at both DRB1 and DQ as significant predictors of overall disease activity during pregnancy. CONCLUSION: Improvement of IBD symptoms during pregnancy is associated with disparity in HLA class II antigens between mother and fetus. This suggests that the maternal immune response to paternal HLA antigens plays a role in pregnancy-induced remission. What is accepted and what this research adds are as follows: The course of IBD during pregnancy is variable; The factors involved with disease course are unknown; The data presented here provides a scientific mechanism for disease course during pregnancy; This is a novel work and it corroborates what has been seen in other autoimmune conditions.

UR - http://www.scopus.com/inward/record.url?scp=4444351659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444351659&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2004.30472.x

DO - 10.1111/j.1572-0241.2004.30472.x

M3 - Article

C2 - 15307871

AN - SCOPUS:4444351659

VL - 99

SP - 1523

EP - 1526

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 8

ER -